B. Riley analyst Bryan Maher raised the firm’s price target on Diversified Healthcare Trust to $4 from $3 and keeps a Buy rating on the shares post the Q2 report.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on DHC:
- Diversified Healthcare sends letter to holders on merger benefits
- DHC Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Largest borrow rate increases among liquid names
- Diversified Healthcare recommends shareholders vote for Office Properties merger
- Flat Footed sends letter to Diversified Healthcare Trust shareholders
